Peptide Therapy · Learning Library
An educational look at BPC-157, the lab-made peptide based on a stomach protein fragment, how it's thought to work in the body and what the research does and doesn't show.
BPC-157 is a short, lab-made chain of 15 amino acids. Its sequence comes from a small piece of a protein found in human gastric juice, which is why you'll sometimes see it called a "body protection compound." It was first studied by researchers in Croatia in the 1990s, and most of what's known about it comes from lab and animal research.
People are most interested in BPC-157 for recovery from tendon, ligament and muscle injuries, for gut health, and for general healing after strain or surgery. Those interests come from animal studies, and well-controlled human trials are still very limited.
Most published work on BPC-157 is in rats and mice, and much of it comes from the same research group. A few small human reports exist, but there isn't yet the kind of large, controlled human trial that would confirm how well it works or what the right dose is. It's also on the World Anti-Doping Agency's prohibited list, so competitive athletes should avoid it.
Because human data is limited, the long-term safety picture isn't well understood. Reported concerns include injection-site reactions, possible immune reactions and the quality of products sold online, which can vary a lot. BPC-157 is not an FDA-approved drug, and its regulatory status for compounding has been changing.
If you're curious whether peptides fit into your health goals, a licensed provider can look at your history and labs and talk through the evidence, the risks and your options.
BPC-157 is a short, lab-made chain of 15 amino acids. Its sequence comes from a small piece of a protein found in human gastric juice, which is why you'll sometimes see it called a "body protection compound." It was first studied by researchers in Croatia in the 1990s, and most of what's known about it comes from lab and animal research.
In animal studies, BPC-157 appears to support angiogenesis, which is the growth of new small blood vessels that bring oxygen and nutrients into injured tissue. It seems to interact with the nitric oxide system, which helps control blood flow and the lining of blood vessels.
People are most interested in BPC-157 for recovery from tendon, ligament and muscle injuries, for gut health, and for general healing after strain or surgery. Those interests come from animal studies, and well-controlled human trials are still very limited.
BPC-157 is not an FDA-approved drug, and its regulatory status for compounding has been changing. Rules around peptides have been changing, so talk with a licensed provider before starting any treatment.
Because human data is limited, the long-term safety picture isn't well understood. Reported concerns include injection-site reactions, possible immune reactions and the quality of products sold online, which can vary a lot. BPC-157 is not an FDA-approved drug, and its regulatory status for compounding has been changing.
This article is general education and isn't medical advice, and it isn't a recommendation to use any substance. Information about research and regulations can change. Talk with a licensed healthcare provider before starting any treatment.